Search & Evaluation Early TA Lead, Director (He)

EMEA, CH, Glattbrugg, CSL Behring

Key information

Publication date:22 January 2026
Workload:100%
Place of work:EMEA, CH, Glattbrugg, CSL Behring

Job summary

Join CSL Behring as a Director of Search & Evaluation, leading innovation! Opportunity to shape the future of immunology, hematology, and cardiovascular/renal therapies.

Tasks

Lead sourcing and evaluation of preclinical and Phase 1 assets.
Drive strategic partnerships and execute early-stage deals effectively.
Represent the TA at conferences, building relationships with biotech communities.

Skills

12+ years in biopharma with a PhD, MD, or equivalent required.
Strong network within biotech and pharma BD organizations.
Deep scientific expertise in relevant therapeutic areas.

Is this helpful?

Three Directors of Search & Evaluation to lead strategic sourcing and evaluation of external innovation opportunities in Immunology, Hematology, and Cardiovascular/Renal therapeutic areas. Embedded within each Therapeutic Area Leadership Team (TALT), these leaders will identify and advance high-potential assets from preclinical through Phase 1 clinical stages, shape early partnering strategies, and drive transactions in collaboration with Business Development

Main Responsibilities & Accountabilities

Lead proactive sourcing and scouting efforts for preclinical and Phase 1 assets, building a robust pipeline of opportunities aligned with TA strategy.

Co-lead internal meetings (with Late Search Lead) focused on evaluating and prioritizing New Product Opportunities (NPOs) within each CSL’s therapeutic areas. NPO meetings are strategic checkpoints where cross-functional teams review potential assets identified by Search and decide whether to advance them for further due diligence and deal negotiations

Develop and execute early partnering strategies, including onboarding approaches and competitive positioning for priority assets.

Drive cross-functional due diligence for each opportunity, coordinating scientific, clinical, regulatory, and commercial assessments to inform governance decisions.

Transaction Execution: Partner closely with BD and Regional Ecosystem Leads to advance high-priority opportunities through negotiation and deal close, ensuring seamless handoff and execution

Represent the TA externally, leading sourcing activities at specialized conferences and cultivating relationships with biotech, academia, and investment communities.

Qualifications & Experience Requirements

12+ years in biopharma with significant experience in external innovation, search & evaluation, or business development.

Advanced degree required (PhD, MD, or equivalent).

Deep scientific expertise in Immunology, Hematology, or Cardiovascular/Renal therapeutic areas.

Proven track record of leading due diligence and closing early-stage deals.

Strong network within biotech, academia, and pharma BD organizations.

Was wir bieten

Wir möchten, dass Sie sich bei CSL wohl fühlen. Das ist wichtig und Sie sind es auch. Erfahren Sie mehr darüber, was wir bei CSL bieten .

Über CSL Behring

CSL Behring ist ein weltweit führendes Unternehmen, das hochwertige Therapeutika für Menschen mit seltenen und ernsten Krankheiten entwickelt und vertreibt. Mit unseren Medikamenten für die Therapiegebiete Immunologie, Hämatologie, Herz-Kreislauf und Stoffwechsel, Atemwegserkrankungen und Transplantationsmedizin halten wir unser Versprechen, die Lebensqualität von Patienten in mehr als 100 Ländern zu verbessern. Erfahren Sie mehr über CSL Behring .

CSL soll so vielfältig sein wie die Welt, in der wir leben

Als globales Unternehmen mit Mitarbeitenden in über 35 Ländern steht CSL für Vielfalt, Fairness und Inklusion. Erfahren Sie mehr über Vielfalt, Fairness & Inklusion bei CSL.